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SINTESIS DAN PENCIRIAN NANO-KELOMPANG KALSIUM FOSFAT 
MENGGUNAKAN TEMPLAT LIPOSOM DOPA DAN DPPA 
 
ABSTRAK 
Kalsium fosfat (CaP) adalah biobahan yang sangat berguna dalam 
kejuruteraan tisu tulang disebabkan ciri-ciri biologi mereka yang istimewa. 
Kesukaran utama yang dihadapi dalam kebanyakan kaedah-kaedah ialah 
pengawalan saiz dan bentuk zarah-zarah CaP. Oleh itu, tujuan projek ini adalah 
untuk mensintesiskan nano-kelompang CaP dengan menggunakan liposom sebagai 
templat supaya saiz dan bentuk zarah-zarah CaP boleh dikawal. Keberkesanan 
liposom (1, 2 dioleoyl-sn-glycero-3-phopshate (garam natrium) (DOPA) dan 1, 2-
dipalmitoyl-sn-glycero-3-phosphate (garam natrium) (DPPA)) sebagai templat 
disiasat dalam permulaan projek ini. Keputusan menunjukkan kedua-dua liposom 
membentuk struktur-struktur bulat liposom unilamellar di mana memenuhi 
keperluan morfologi dan saiz templat nano-kelompang CaP dengan menggunakan 
kaedah penyediaan yang sesuai. Kesan kepekatan NaOH (0.025 M, 0.050 M, 0.075 
M, 0.100 M atau 0.125 M) dan ion-ion kalsium (Ca
2+
) (0.050 M, 0.100 M, 0.150 M 
atau 0.200 M) bagi ciri-ciri nano-kelompang CaP disediakan dengan menggunakan 
templat liposom DOPA dan DPPA dikaji seterusnya. Natrium hidroksida (NaOH) 
memainkan peranan sebagai satu penyelesaian asas untuk meningkatkan pH dan 
mengawal penepuan lampau campuran nano-kelompang CaP. Ca
2+ 
pula ialah satu 
lagi parameter utama yang mempengaruhi elektrostatik setempat dengan templat 
liposom dan pertumbuhan CaP pada templat liposom. Morfologi, nisbah molar akhir 
kalsium-kepada-fosforus (Ca/P), saiz zarah, taburan saiz zarah, keupayaan zeta, 
kumpulan berfungsi dan fasa nano-kelompang CaP telah dinilaikan dengan 
xvi 
 
mikroskop elektron imbasan pancaran medan (FESEM), mikroskop elektron 
penghantaran (TEM), spektrometer sinar-X serakan tenaga (EDX), Nano Zetasizer 
ZS, spektroskop inframerah jelmaan Fourier (FTIR) dan pembelauan sinar-X (XRD). 
Daripada penyelidikan dengan kepekatan NaOH dan Ca
2+ 
yang berbeza, hasilan 
terbaik dalam projek ini menunjukkan nano-kelompang CaP yang bulat dengan 
nisbah molar akhir Ca/P 0.97 terbentuk pada pH 10.52 dengan menggunakan 
templat DOPA apabila 0.100 M NaOH dipadankan dengan 0.100 M Ca
2+ 
digunakan. 
Di sebaliknya, zarah-zarah berbentuk jarum atau tidak teratur telah diperhatikan 
dalam nano-kelompang CaP disediakan dengan templat liposom DPPA. Penyediaan 
nano-kelompang CaP dengan menggunakan templat liposom DOPA dan DPPA 
telah ditunjukkan sebagai habluran sebahagiannya (yang digalakkan dalam aplikasi 
perubatan) atau amorfus dalam analisis FTIR dan XRD. Keputusan menunjukkan 
CaP yang disediakan tanpa templat mempunyai zarah-zarah terkumpul yang besar, 
tidak stabil dan dihablurkan disebabkan pertumbuhan penukleusan seragam di mana 
menceburi mekanisma pertumbuhan penukleusan-pengagregatan-pengaglomeratan. 
Sebagai tambahan, dari mekanisma pertumbuhan, ia telah didapati bahawa 
kestabilan templat liposom boleh mempengaruhi pertumbuhan penukleusan 
heterogen nano-kelompang CaP di mana adalah satu faktor mustahak dalam sintesis 
nano-kelompang CaP. 
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SYNTHESIS AND CHARACTERISATION OF CALCIUM PHOSPHATE 
NANOSHELLS USING DOPA AND DPPA LIPOSOME TEMPLATES  
 
ABSTRACT 
Calcium phosphates (CaPs) are very useful biomaterials in bone tissue 
engineering due to their excellent biological properties. The major difficulties facing 
in most of the synthesising methods are the size and the shape-controlling of CaP 
particles. Therefore, the aim of this project is to synthesise CaP nanoshells by using 
liposomes as template in order to control the particle size and the shape of the CaP 
particles. The effectiveness of liposomes (1, 2 dioleoyl-sn-glycero-3-phosphate 
(sodium salt) (DOPA) and 1, 2-dipalmitoyl-sn-glycero-3-phosphate (sodium salt) 
(DPPA)) as template were firstly investigated in this project. The results showed that 
both liposomes formed spherical structures of unilamellar liposomes, in which fulfil 
the morphology and the size requirement of templates of CaP nanoshells by using 
suitable preparation method. The effect of concentrations of sodium hydroxide 
(NaOH) (0.025 M, 0.050 M, 0.075 M, 0.100 M or 0.125 M) and calcium ions (Ca
2+
) 
(0.050 M, 0.100 M, 0.150 M or 0.200 M) to the properties of CaP nanoshells 
prepared using DOPA and DPPA liposome templates were then studied. NaOH 
plays the role as a base solution to increase the pH, and thus, control the 
supersaturation of the mixture of CaP nanoshells. In addition, Ca
2+ 
is another main 
parameter to influence the electrostatic localisation with liposome template and the 
growth of the CaPs on the liposome template. The morphology, final calcium-to-
phosphorus (Ca/P) molar ratio, particle size, particle size distribution, zeta potential, 
functional group and phase of CaP nanoshells were evaluated by field emission 
scanning electron microscopy (FESEM), transmission electron microscopy (TEM), 
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energy dispersive X-ray spectrometer (EDX), Zetasizer nano ZS, Fourier transform 
infrared spectroscopy (FTIR) and X-ray diffraction (XRD). From the investigation 
of different concentrations of NaOH and Ca
2+
, the best results in this project showed 
that spherical CaP nanoshells with Ca/P molar ratio of 0.97 were formed at pH of 
10.52 by using DOPA liposome template when 0.100 M of NaOH coupled with 
0.100 M Ca
2+ 
were used. In contrast, the needle or irregular shaped particles were 
observed in the CaP nanoshells prepared with DPPA liposome template. CaP 
nanoshells prepared using DOPA and DPPA liposome templates were indicated as 
poorly crystalline (favorable in biomedical application) or amorphous in FTIR and 
XRD analyses. Results showed that the CaPs prepared without template had large 
and unstable of agglomerated and crystallised particles due to the homogenous 
nucleation growth, in which involved growth mechanism of nucleation-aggregation-
agglomeration. In addition, from growth mechanism, it was found that the stability 
of liposome template can influence the heterogeneous nucleation growth of CaP 
nanoshells, in which is an important factor in the synthesis of CaP nanoshells. 
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CHAPTER ONE: 
INTRODUCTION 
  
This chapter provides the detail of introduction for this project. Brief 
definitions and advantages of calcium phosphate (CaP) nanoshells are included in 
the beginning of the chapter. The problem statement, scope of study, objectives and 
thesis organisation of this project are also included in this chapter. 
 
1.1 Calcium Phosphates (CaPs) as Bone Biomaterials 
CaPs including hydroxyapatite (HA), alumina (Al2O3), zirconia (ZrO2), silica 
(SiO2) based glasses or bioactive glasses (Shi, 2006), generally termed as 
biomaterials which have both biochemical compatibility and biomechanical 
compatibility (Cao and Hench, 1996). Over the last decades, research in the field of 
CaPs has been increased very rapid. The number of published journal articles related 
to CaPs has rapidly increased as shown in Figure 1.1. This shows the importance of 
this field of research. These biomaterials have been used as bone biomaterials such 
as bone substitutes or bone replacement (Giannoudis et al., 2005; Paul and Sharma, 
2006; Mastrogiacomo et al., 2006; Habibovic and Barralet, 2011; Fergal, 2011). They 
have also been used to guide and develop the bone healing tissue, to become 
integrated within it and then subjected to the same remodelling process as the 
natural bone (Frayssinet et al., 1998). Moreover, they can help in achieving the best 
possible level of care for patient’s sake.  
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Figure 1.1: Number of published articles related to CaPs as a function of publication 
year (Data obtained at 29 March 2011 through the ISI web of knowledge search). 
 
CaPs are composed of ions commonly found in the physiological 
environment (e.g., calcium (Ca), sodium (Na)) (Hulbert et al., 1972), which make 
them highly biocompatible. In addition, these biomaterials are also non-toxic, non-
allergic, and also resistant to microbial attack, pH conditions (de Groot et al., 1990; 
Hench, 1998; Kalita et al., 2007). Thus, CaP biomaterials are very useful 
biomaterials. However, the applications of CaP biomaterials have been limited to 
small, unloaded and lightly-loaded implant (Shi, 2006) due to their very poor 
mechanical properties.  
 
1.2 Why Calcium Phosphate (CaP) Nanoshells? 
Nanotechnology has achieved the position as one of the critical research 
endeavors of the early 21
st
 century (McNeil, 2005). The study of CaPs as 
biomaterials is a specific area in nanotechnology. An obvious advantage of 
nanotechnology as it relates to biological systems is the ability to control the size of 
the resulting particles (Parashar et al., 2008). Many advances have been made in 
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biomaterials with the rapid growth of nanotechnology. According to many reports, 
the size of apatite in biological hard tissues always possesses a range of a few to 
hundreds of nanometers (Weiner and Addadi, 1997; Weiner and Wagner, 1998; 
Boskey, 2003).  
 
CaPs have been used widely in medicine and dentistry application as bone 
biomaterials due to their excellent biological properties. Although CaPs can fulfil 
some of the characteristics of bone, CaP still have some limitations in clinical 
applications such as poor adaptation to the shape of bone cavities and fixation 
problems when granules are used (Fernández et al. 1999a; Fernández et al. 1999b).  
This is due to the potential of CaPs used in vivo depend upon their ability to 
withstand complex stresses at the site of application and their compatibility with the 
biological environment (Kalita et al., 2007). Besides, CaPs have very poor 
sinterability and poor mechanical properties such as very low compressive strength. 
This limits the applications of CaPs to small, unloaded and lightly-loaded 
applications such as osteoconductive coatings on metallic prosthesis and as nano-
powders in spinal fusion. Moreover, surgeons reported on difficulties in filling the 
vertebral bodies (a bad injectability of present formulations) (Dorozhkin, 2008). The 
poor injectability also reduces the application of CaP biomaterials. 
 
In addition, the mechanical and biological performance of CaPs depends 
highly on the chemical composition and physical characteristics such as structure, 
crystal and particle size (Rey, 1990; Best, 1994; Lu et al., 2002a). Thus, it is 
important in controlling these characteristic features in order to improve the 
performance of CaPs.  Nanotechnology is one of the approaches, which has been 
4 
 
explored recently to improve both the strength and toughness of CaPs to make them 
useful in load-bearing applications (Kalita et al., 2007). Many of the deficiencies of 
CaPs such as poor mechanical strength, poor sinterability and poor injectability can 
be improved if the CaPs prepared in nanoscale structure (Bohner and Baroud, 2005; 
Kalita et al., 2007). For example, nanostructured HA demonstrated excellent 
chemical and microstructural uniformity and mechanical properties, compared to 
conventional HA (Ahn et al., 2001). In addition, it was verified that nanocomposites 
in nature show a standard mechanical structure in which the size in nanoscale of 
mineral particles are used to ensure optimum strength and maximum tolerance of 
flaws (Gao et al., 2003).  
 
However, the research in the synthesis of CaP nanoshells is yet to be 
extensively studied although the number of published articles for the formation of 
nanoshells has increased rapidly in the past decades as shown in Figure 1.2. CaP 
nanoshells are hollow solution-filled nanoparticles in size range of 20 nm to 200 nm 
that prepared by coating liposomes with nanometre thick layer of inorganic CaPs. 
The small sizes and spherical shape of nanoshells make them ideal for injection to 
the human body (Ishikawa, 2003; Wingert et al., 2007; Dorozhkin, 2008; Sounderya 
and Zhang 2008). Thus, CaP nanoshells are promising candidates for used in 
medical and dentistry application. Moreover, various synthesis routes have been 
developed over the past few years to prepare nanoshell based materials such as 
interfacial polymerisation (Scher et al., 1998; Vincent, 2006), layer-by-layer 
deposition (Ai et al., 2003; Vincent, 2006),  sol-gel method (Pal and Chakravorty, 
2005; Chatterjee, et al., 2005; Basu and Chakravorty, 2006)  and others. Thus, 
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synthesis of CaP nanoshells is the most important issue to be addressed as it controls 
the properties of the final CaP nanoshells. 
 
 
 
Figure 1.2: Number of published articles related to nanoshells as a function of 
publication year (Data obtained at 29 March 2011 through the ISI web of knowledge 
search). 
 
1.3  Problem Statement  
The major problem created by bone disease, especially osteoporosis, is 
fractures, which may be the first visible sign of disease in patients (Office of the 
Surgeon General, 2004). Osteoporosis affects an estimated 75 million people in 
Europe, USA and Japan (European Foundation for Osteoporosis and The National 
Osteoporosis Foundation, 1997). In Malaysia, it is estimated that over 1 million 
people are at risk of osteoporosis, out of which 80 % are women (Arthritis 
Foundation Malaysia, 2011). CaPs are the biomaterials of choice in both dentistry 
and medicine in order to solve the problem. The recent trend in this field of research 
is focused on overcoming the limitations of CaPs and in improving their biological 
properties by exploring the unique advantages of nanotechnology (Kalita et al., 
2007). In addition, the great challenge in this research field is to develop synthesis 
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method that is able to control the particle size and shape of CaPs uniformly (Hu et 
al., 2010).  
 
In this research, CaP nanoshells by using 1, 2-dioleoyl-sn-glycero-3-
phosphate (sodium salt) (DOPA) and 1, 2-dipalmitoyl-sn-glycero-3-phosphate 
(sodium salt) (DPPA) liposomes as template will be synthesised in order to control 
the particle size and shape. The small sizes and spherical shape of nanoshells make 
them ideal to be used in the human body such as ease for injection to the body 
(Ishikawa, 2003; Dorozhkin, 2008; Sounderya and Zhang 2008). Since the shape of 
the materials can be controlled by the shape of the template used (Pileni, 1998), the 
synthesis method using a template are being explored. For example, Tjandra et al. 
(2006) reported the use of polymeric template to synthesise hollow spherical CaP 
nanoparticles. However, the removal of this polymeric template is needed. Thus, 
liposomes are preferred in this research because they are non-toxic, biodegradable 
and non-immunogenic in nature, and thus, they can remain in the human body 
(Lasic, 1995). In addition, the negatively charged polar headgroup (-OH) of 
liposomes can assist in the localisation of calcium ions (Ca
2+
) around the liposomes 
(Schmidt et al. 2004).  Nevertheless, the effectiveness of template in controlling the 
shape of CaP nanoshells can be affected since some discrepancies arise in the 
synthesis using template (Pileni, 2003). Therefore, the various parameters affecting 
their size and shape still need to be investigated in order to produce CaP nanoshells 
which have better properties compared to existing CaP materials. In this project, 
sodium hydroxide (NaOH) plays the role to increase the pH, and thus, to control the 
supersaturation of the mixture of CaP nanoshells (Schmidt, 2006).  Moreover, the 
addition of NaOH is known to have a large impact on the particle formation 
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(Nishimura et al., 2011). In addition, Ca
2+
 is another main parameter to influence the 
electrostatic localisation with liposome template and the growth of the CaPs on the 
liposome template (Schmidt et al., 2004). Hence, in this research, NaOH and Ca
2+
 
are the main parameters to be investigated in the synthesis of CaP nanoshells using 
DOPA and DPPA liposome templates.   
 
1.4 Research Objectives 
The main goal of this study is to synthesise the CaP nanoshells by using 
liposomes as template in order to control their particle size and shape. The 
objectives in this project are as following: 
i. To investigate the effectiveness of DOPA and DPPA liposome templates 
ii. To synthesise CaP nanoshells by using DOPA and DPPA liposome 
templates  
iii. To study the effect of concentrations of NaOH and Ca2+ to the properties 
of the synthesised CaP nanoshells using DOPA and DPPA liposome 
templates  
iv. To study the growth mechanism of the synthesised CaP nanoshells 
 
1.5 Scope of Study 
The first step in this project is to study the DOPA and DPPA liposomes. The 
effectiveness of both liposomes to be used as template in the synthesis of CaP 
nanoshells is investigated. The results are crucial as basic information required to 
prior to conduct the further experimental works. 
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Secondly, CaP nanoshells by using DOPA and DPPA liposomes templates 
are synthesised. The effect of the experimental conditions for concentrations of 
NaOH and Ca
2+
 on properties of CaP nanoshells is also studied. Moreover, CaP 
nanoshells with and without liposome templates are studied and compared in the 
research work. 
 
Transmission electron microscopy (TEM), field emission scanning electron 
microscope (FESEM), energy-dispersive X-ray spectrometer (EDX), Zetasizer nano 
ZS, Fourier transform infrared spectroscopy (FTIR) and X-ray diffraction (XRD) are 
used to characterise the physical and elemental properties of the CaP nanoshells. 
TEM is used to investigate morphological of liposomes and CaP nanoshells in very 
high resolution. The main purpose of using FESEM and EDX are to study surface 
topography of CaP nanoshells and to determine the composition of elements 
presented in the final products, respectively. The particle size and zeta potential of 
the liposome templates and CaP nanoshells are measured by using Zetasizer nano 
ZS. FTIR is used to observe the development of functional groups and XRD is used 
to determine the phases formed. 
 
Lastly, growths mechanisms of the formation of CaP nanoshells with and 
without liposome templates are developed based on the results of characterisation. 
The growths mechanisms are useful to understand the synthesis of CaP nanoshells. 
 
1.6  Organisation of The Thesis 
This thesis consists of five chapters. Chapter one provided an outline of the 
overall research project including the introduction of CaPs as biomaterials and the 
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reason the CaPs need to be prepared in nanoshells. Project statement was written 
after reviewing the existing CaPs. This revealed the problems faced and the 
importance of this research project. The objectives of this research project were then 
carefully formulated with the intention to address the problems. The main objective 
here was to synthesise the CaP nanoshells by using liposomes as template in order to 
control the particle size and shape of CaP nanoshells. Besides, the effect of 
concentrations of NaOH and Ca
2+
 to the properties of the CaP nanoshells and also 
their growth mechanism were studied.  
 
Chapter two contains the background information of various research works 
reported in the literature in this area of study which includes types of CaP 
biomaterials, type of liposomes and their preparation methods, various methods to 
synthesise CaP nanoshells. In addition, the potentials applications of CaP nanoshells 
are discussed. 
 
The experimental materials and methodology used in this research are 
discussed in chapter three. This chapter describes the details information on the 
overall flow of this research works and the experimental methods in conducting the 
project. The synthesis parameters to be investigated and the characterisation 
techniques of the CaP nanoshells are also described here. 
 
Chapter four is the heart of this thesis as it includes the detail discussion on 
the results obtained in the research work. This chapter is divided into four sections 
according to the stages and experimental conditions of this research work. First 
section presents the characterisation of prepared liposomes that had been done 
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before further experimental works are carried out. Section two reports the effect of 
concentrations of NaOH and Ca
2+
 the properties of CaP nanoshells by using DOPA 
and DPPA liposome templates. Section three represents the comparison between 
CaP nanoshells with and without liposome templates produced under optimum 
conditions. At the end of this chapter, growth mechanism of CaP nanoshells with 
and without liposome templates also discussed. 
 
Chapter five, the last chapter of the thesis, gives a summary on the results 
obtained in this project.  This chapter also gives some recommendations for future 
studies related to this project. 
 
 
 
11 
 
CHAPTER TWO: 
LITERATURE REVIEW 
 
This chapter reported the literature related to this research project which is 
CaP nanoshells prepared by using liposomes as template. Overview of CaP based 
bone biomaterials, types of CaP biomaterials, nanoshells, CaP nanoshells, types of 
liposomes and their preparation method are provided. Various synthesis methods of 
liposome based CaP nanoshells and their potential applications are explained in 
more detail. 
 
2.1 Brief Introduction on Calcium Phosphate (CaP) and Nanoshells 
CaPs have attracted great attention in medicine and dentistry as bone 
biomaterials due to their excellent biocompatibility and bone-repair properties. In 
fact, the mineral fraction of hard tissues is composed of sparingly soluble CaPs 
(Fernández et al., 1999c). The requirements of bone biomaterials especially bone 
substitutes are good local and systemic compatibility, the capability of being 
substituted by bone and of entirely filling any flaw. These features require 
osteoconductive and/or osteoinductive properties of the bone substitutes, thus CaPs 
are the primary materials of choice for their application.  
 
Although CaPs can fulfill the characteristics of bone, CaPs still have some 
limitations in clinical applications such as poor adaptation to the shape of bone 
cavities and fixation problems when granules are used (Fernández et al., 1999c).  
Moreover, the poor mechanical properties of CaPs also limit their applications in 
orthopaedics. To overcome the weakness of CaPs, a broad range of materials have 
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been proposed to reinforce CaPs, including carbon nanotubes (CNTs) (Chew et al., 
2011; Low et al., 2011), polymers (Rezwan et al., 2006; Neumamn and Epple, 2006; 
Yunos et al., 2008) such as chitosan (Xu and Simon, 2005), poly(D,L-lactic-co-
glycolic acid) (PLGA) (Durucan and Brown, 2000) and poly(lactide acid) (PLA) 
(Mickiewicz et al., 2002). However, the research related to nanoshell based CaPs is 
rarely reported. 
 
Nanoshells can be defined as nanoscale structures containing a rigid shell 
surrounding a solid and/or liquid core (template) composed of a different material. 
Nanoshells are typically in the size range of 20 nm to 200 nm (Sounderya and Zhang 
2008). Their sizes are small enough to make them ideal for targeted injection to 
specific zones of the body. Nanoshells can enhance the thermal and chemical 
stability, improve solubility and have less cytotoxic (Ishikawa, 2003; Dorozhkin, 
2008; Sounderya and Zhang 2008). Various synthesis routes have been developed 
over the past few years to prepare nanoshells such as interfacial polymerisation 
(Scher et al., 1998; Vincent, 2006), layer-by- layer deposition (Ai et al., 2003; 
Vincent, 2006),  sol-gel method (Pal and Chakravorty, 2005; Chatterjee, et al., 2005; 
Basu and Chakravorty, 2006)  and others. The great challenge in this research field 
is to develop synthesis method that can control the particle size and shape uniformly 
(Hu et al., 2010). Nanoshells have a plethora of applications related with them. For 
instance, they are used in imaging cancer cells and other therapeutic applications 
(Kalele et al., 2006). In this project, the idea of nanoshells is expected to improve 
the drawback of CaPs. 
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2.2 Calcium Phosphate (CaP) Based Bone Biomaterials  
Bone is organic- inorganic hybrid composite of protein and mineral with 
superior strength, hardness and fracture toughness (Gao et al., 2003). Bone can be 
categorised as short, flat, and tubular. The function of the bone is to mainly 
withstand the forces imposed by normal activities (Shi, 2006). 
 
In Europe, USA and Japan, osteoporosis perhaps affects 75 million people 
(European Foundation for Osteoporosis and The National Osteoporosis Foundation; 
1997). It is also estimated that over 1 million people in Malaysia are at risk of 
osteoporosis (Arthritis Foundation Malaysia, 2011). The biggest problem created by 
osteoporosis, one of the bone diseases, is fractures, which may be the first noticeable 
symptom of disease in patients. The problem becomes a chronic burden on 
individuals and even the public. The risk of fracture increases dramatically with age 
in both sexes. This may be due to bones become more fragile and the risk of falling 
increases (Office of Surgeon General, 2004). In recent years, there has been 
considerable progress in understanding bone biomaterials (e.g., bone substitutes). 
This has noteworthy implications for the future management of bone loss (Chow, 
2009). 
 
The attempt to discover substitutions for repair of fatally damaged human 
bones dated back to centuries (Katti, 2004). The common principle for materials 
selection in the finding of new bone biomaterials are biocompatibility and 
mechanical performance. Metals usually show excellent mechanical properties but 
have poor biocompatibility at the same time, causing stress shielding and release of 
unsafe metal ions, and thus resulting ultimate failure and removal of implant. In 
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general, polymeric materials alone tend to be too weak to be suitable for meeting the 
condition of stress deformation responses in human bone such as total hip 
substitution components. Ceramics were investigated as bone substitute biomaterials 
owing to their simplicity of processing and forming, good biocompatibility, 
mechanical strength and toughness (Katti, 2004). Because of lack of chemical 
bonding between conventional ceramics such as sintered Al2O3 and tissue, their 
applications as a potential bone substitute are restricted  (LeGeros, 2008). Since the 
composite materials with engineered interfaces resulting in combination of greater 
biocompatibility and mechanical performance, the focuses of many existing 
researches are composite materials such as CaP based composites (Katti, 2004).  
 
CaPs have been extensively investigated due to the similarities with the bone 
mineral and their structural and surface features are accountable for their superior 
biocompatible as well as bioactive properties, has the ability to interact with the 
biological milieu to enhance the biological response (Navarro et al., 2008). 
Moreover, the CaP biomaterials are osteoconductive materials that only allow the 
formation of bone on their surface by serving as a scaffold. In patients with 
diminished bone forming ability, bone tissues do not necessarily bond to CaP 
biomaterials at a clinically satisfactory level. Moreover, the osteoblasts are the cells 
responsible for the growth of the bone matrix and are found on the developing bone 
surface. If the CaP biomaterials possess osteoconductive and osteoblasts properties, 
the expansion of clinical application for the CaP biomaterials is a certain (Salata, 
2004; Ito and Ohgushi, 2005).  
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Another important property of bone is the osteoinductivity that allows the 
bone to repair and regenerate itself. However, CaP biomaterials are commonly 
known to be osteoconductive but not osteoinductive (LeGeros, 1991; LeGeros, 
2008). Osteoinductive properties can only be introduced to CaP biomaterials by 
designing the CaPs with appropriate geometry, topography, combined appropriate 
macroporosity/microporosity and concavities that will allow the entrapment and 
concentration of circulating growth factors or osteoprogenitor cells responsible for 
bone formation or combining CaP with growth factors or bioactive proteins 
(LeGeros, 1991). 
 
2.3 Types of Calcium Phosphate (CaP) Biomaterials 
There are many types of CaP biomaterials in clinical applications including 
CaP ceramics, calcium phosphate cements (CPCs) and CaP based composites 
(LeGeros, 2008). All these CaP biomaterials are described with a brief introduction 
to help understanding of CaP biomaterials.  
 
2.3.1 Calcium Phosphate (CaP) Ceramics 
A variety of dense and porous CaP ceramics have been developed in various 
forms including HA from synthetic or natural (from coral), calcium-deficient 
hydroxyapatite (CDHA), TCP (α-tricalcium phosphate (α-TCP) and β-tricalcium 
phosphate (β-TCP)), biphasic calcium phosphate (BCP), tetracalcium phosphate 
(TTCP) and amorphous calcium phosphate (ACP) (Fernández, 1999a; Fernández, 
1999b; Dorozhkin, 2009a). The properties of these CaP ceramics are listed in Table 
2.1. CaP ceramics in blocks or granules are the main raw materials used for bone 
substitutes (Suchanek and Yoshimura, 1998). These forms are not suitable when 
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cavities are not straightforwardly accessible or when it would be preferable to carry 
out microinvasive percutaneous surgery (Low et al., 2010).  
 
Table 2.1: The properties of various phases of CaP ceramics. 
CaP ceramics 
Chemical 
formula 
Ca/P ratio 
pH stability 
range in 
aqueous 
solutions at 
25°C 
References 
Amorphous calcium 
phosphate (ACP) 
Cax(PO4)y·nH2O, 
n=3-4.5; 15-20% 
H2O 
1.20-2.20 ~5-12 Dorozhkin, 2009a 
α-tricalcium phosphate 
(α-TCP) 
Ca3(PO4)2 1.50 [a] Fernández, 1999a; 
Dorozhkin, 2009a  
β-tricalcium phosphate 
(β-TCP) 
Ca3(PO4)2 1.50 [a] Fernández, 1999a; 
Dorozhkin, 2009a  
Calcium-deficient 
hydroxyapatite (CDHA) 
Ca10-
x(HPO4)x(PO4)6-x 
(OH)2-x; (0<x<1) 
1.50-1.67 6.5-9.5 Fernández, 1999b; 
Dorozhkin, 2009a 
Hydroxyapatite (HA) Ca10(PO4)6(OH)2 1.67 9.5-12 Fernández, 1999a; 
Dorozhkin, 2009a 
Tetracalcium phosphate 
(TTCP) 
Ca4(PO4)2O 2.00 [a] Fernández, 1999a; 
Dorozhkin, 2009a  
Note: [a] These compounds cannot be precipitated from aqueous solutions. 
 
The ACP phase is an intermediate phase in the preparation of a number of 
CaPs. ACP occurs in many biological systems, particularly in primitive organisms, 
where it is believed to provide a reservoir of Ca2+ and PO4
3-. ACP is 
straightforwardly converted into poorly crystalline apatite comparable to bone 
mineral crystals and benefit can be taken of its high reactivity to produce bioactive 
biomaterials (Combes and Rey, 2010). ACP plays a crucial role in the 
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biomineralisation of bone as it is a precursor to crystalline bone apatite (Li et al., 
2007). Moreover, ACP is extensively used as a precursor to prepare crystalline CaPs 
with different compositions (Layrolle et al., 1998). ACP based biomaterials are used 
in the form of coatings, cements, ceramics or composites (see Table 2.2). The 
instability of ACP raises issues for mass production, storage and processing that 
limit the improvement of ACP based biomaterials (Combes and Rey, 2010). 
 
Table 2.2: ACP based biomaterials (Combes and Rey, 2010). 
Type of ACP based 
biomaterials 
Applications Main CaP-related effects 
Ionic cements Bone substitute  Active hardening agents 
 Dental applications Bioresorbable surface reactivity 
Provider of Ca
2+
 and PO4
3-
 ions 
Coatings Coating of metallic prostheses Biodegradable and reactive 
coating 
Mineral-organic composites Teeth, enamel remineralisation Mechanical properties 
 Bone substitute  Ca and PO4 release in relation 
with  biological activity 
 
HA is a bioactive ceramics commonly used as powders or in particulate 
forms as coatings for metallic prostheses to enhance their biological properties (Liu 
et al., 2001). In addition, HA has also been used for a range of biomedical 
applications such as bone tissue regeneration, cell proliferation, and drug delivery 
(Sopyan et al., 2007). HA is the ideal phase for use inside human body as it has 
outstanding stability above pH 4.30 (human blood pH being 7.30) and can show 
strong relation to host hard tissues owing to the chemical similarity between HA and 
mineralised bone of human tissue (Kalita et al., 2007). However, HA remains in the 
human body for a long time after implantation (Kamitakahara et al., 2008). 
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Moreover, the mechanical properties of HA is very poor as compared to human bone. 
Meanwhile, the bone mineral present a greater bioactivity as compared to HA 
(Kalita et al., 2007).  
 
As a first approximation, CDHA similar to bone mineral and may be 
considered as HA although lacking the ionic substitutions (Brown and Martin, 1999; 
Dorozhkin, 2009a). It is a poorly crystalline material with a ratio of calcium-to-
phosphorus (Ca/P) varying between 1.50 and 1.67 (Mickiewicz, 2001). The structure 
contains vacant Ca2+ and hydroxide ion (OH-) sites, whereas some of the phosphate 
ion (PO4
3-) are either protonated or substituted with other ions (Boanini et al., 2010). 
Because of a lack of stoichiometry, CDHA often occurs with ionic substitutions 
(Dorozhkin and Epple, 2002). The extent depends on the counter- ions of the 
chemicals used for preparation. Direct determinations of the CDHA structures are 
still missing and the unit cell parameters remain uncertain. The ion substituted 
CDHA, such as sodium ion (Na+) for Ca2+ with some water forms biological apatite 
addition which is the main inorganic part of animal and human normal and 
pathological calcifications (LeGeros, 1991; Rey et al., 2006; O’Neill, 2007). Hence, 
CDHA is a very promising compound for industrial manufacturing of synthetic bone 
substitutes. 
 
One might expect that implanted materials should exhibit resorbable 
property through bone regeneration, followed by complete substitution for the 
natural bone tissue after stimulation of bone formation. Therefore, for bone 
regeneration, much attention has been paid to TCP as scaffold materials 
(Kamitakahara et al., 2008). It has been proved to be resorbable in vivo with new 
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bone growth replacing the implanted TCP (Gibson et al., 2000). The two forms of 
TCP that are known to exist are α-TCP and β-TCP. β-TCP transforms into a high-
temperature phase, α-TCP at temperatures above 1125 ºC. At room temperature, β-
TCP is more stable than the α-TCP. In addition, β-TCP as stable phase is less 
soluble in water than α-TCP (Yin et al., 2003). Thus, α-TCP has received very little 
attention in the field of biomedical application. The drawback for using α-TCP is its 
speedy resorption rate in which limits its usage in this area (Metsger et al., 1999). In 
contrast, β-TCP is basically a gradually degrading bioresorbable CaP ceramic 
(Driessens et al., 1978). Therefore, it is a promising material in the field of 
biomedical applications. It has also been observed to have considerable biological 
affinity as well as activity and responds very well to the physiological environments 
(Kivrak and Tas, 1998). These factors give β-TCP an edge over other biomedical 
materials when it comes to resorbability and substitution of the implanted TCP in 
vivo by the new bone tissue (Gibson et al., 2000). It is reported that the resorbability 
of β-TCP in vivo might be strongly associated to the characterisation and stability of 
the β-TCP structure (Okazaki and Sato, 1990; Kalita et al., 2007). 
 
A bioactive idea developed for BCP ceramics. The idea is based on an 
optimal balance of the more stable phase of HA and more soluble TCP (Daculsi, 
1998). Daculsi (1998) prepared BCP macroporous ceramics consisting of a β-TCP 
and HA with dissimilar β-TCP/HA mass ratios, and implanted them in osseous 
defects in dogs. BCP ceramics have been considered to be a promising scaffold for 
utilise with tissue engineering strategies for bulky bone defect reconstruction. BCP 
ceramics change according to their chemical composition and physical structures, 
which in conjunction with the implantation site, form (e.g., granules, blocks and 
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customised pieces) and the intrinsic conditions of the patient, can give rise to 
dissimilar rates and patterns of human bone development (Lobo and Arinzeh, 2010). 
The resorbability of BCP ceramics was enhanced with raising the β-TCP/HA mass 
ratio. They remarked the formation of bone- like apatite crystals on the BCP 
ceramics surfaces, which was associated with the β-TCP/HA ratios of the BCP 
ceramics. They hypothesised that the formation of the bone-like apatite may be 
owing to the precipitation of Ca2+ and PO4
3- released from the β-TCP component in 
the BCP ceramics. In order to apply suitable BCP to meet specific biological needs, 
it is essential to control the BCP ceramics by altering their β-TCP/HA ratios (Cho et 
al., 2010). However, it also proposed that the combination of β-TCP with HA may 
lead to more complexes biological and chemical incidents caused by both β-TCP 
and HA (Kamitakahara et al., 2008). The knowledge of such parameters is necessary 
in choosing a BCP for a particular application (Lobo and Arinzeh, 2010). 
 
For TTCP, its solubility in water is higher as compared to that of HA 
(Dorozhkin, 2007). TTCP cannot be precipitated from liquid solutions. Therefore, it 
can only be prepared by a solid-state reaction above 1300 °C. It is very unstable in 
liquid solutions and it gradually hydrolyses to HA and calcium hydroxide (CaOH) 
(Dorozhkin, 2009a). As a result, TTCP has never been found in biological 
calcifications. TTCP is usually used in medicine for the forming of various self-
setting cements. Nonetheless, the synthesis and applications of TTCP in nanoscale 
have not much been reported (Kalita et al., 2007). 
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2.3.2 Calcium Phosphate Cements (CPCs)  
CPCs are injectable paste- like materials that harden in the human body (Ito 
and Ohgushi, 2005). CPCs consisting of mixtures of different CaP phases, such as β-
TCP, TTCP, monocalcium phosphate monohydrate (MCPM), dicalcium phosphate 
dehydrate (DCPD or brushite), dicalcium phosphate anhydrous (DCPA or monetite) 
and octacalcium phosphate (OCP). They are mixed with water in a liquid-to powder 
(L/P) ratio of 1:4 to form a paste that can be conventional to osseous defects with 
complex shapes and set in vivo to form HA with tremendous osteoconductivity 
without any acidic or basic by-product (Brown and Chow, 1985; Bai et al., 1999). 
The improvement of self-setting CPCs has extended the use of CaPs to injectable 
bone substitutes that can be moulded and shaped to fit irregular defects, and reveal 
osteo- integrative properties similar to or better than those of bulk CaPs (Brown and 
Chow, 1985). They had been chosen for clinical use because of their suitability for 
repair, augmentation, regeneration of bones and the advantages related self-
hardening properties of the cements (Chow, 2009). 
  
 Table 2.3 lists the properties of three common formulations of CPCs 
(Schmitz et al., 1999). In a nutshell, the advantages of CPCs include being injectable, 
moldable, to adapt to the human bone defects, to exhibit excellent biocompatibility 
and to be osteoconductive. CPCs also have their weakness in modestly invasive 
clinical applications, in which is their low capability to be injected through a thin 
long cannula attached to a syringe (Khairoun et al., 1998; Leroux et al., 1999; 
Bohner and Baroud; 2005; Low et al., 2010). Research efforts on CPC have been 
somewhat unfocused so that despite a wealth of knowledge gained, clinical 
applications of CPC remain limited to a relatively narrow area (Chow, 2009). 
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Table 2.3: Properties of CPCs (Schmitz et al., 1999). 
Formulation Bone Source α-BSM Embarc Norian SRS/CRS 
Components TTCP and DCPD  Decarbonated ACP and 
either DCPD, calcium 
metaphosphate, 
calcium 
heptaphosphate, 
calcium pyrophosphate, 
or TCP 
Monocalcium 
phosphate, α-TCP, 
calcium carbonate 
Compressive strength 36 MPa (for first 24 h) Unknown 55 MPa 
Resorbable Minimally Yes Completely 
Commercially available  Yes Yes Yes 
Pore diameter 2 – 5 nm Unknown 300 Å 
Initial setting time 10 – 15 min 15 -20 min 10 min 
Final setting time 4 h 1 h 12 h 
Osteoconductive Yes Yes Yes 
Sets in presence of fluid No (must be kept dry) Yes Yes 
 
2.3.3 Calcium Phosphate (CaP) Composites 
The goal for development of composite materials has been achieved by a 
combination of properties of various materials which not achievable by any of the 
elemental materials acting alone (Göller et al., 2003). Thus, CaP is commonly used 
in combination with various materials including CNTs (Chew et al., 2011; Low et 
al., 2011), polymers (Rezwan et al., 2006; Neumamn and Epple, 2006; Yunos et al., 
2008) such as chitosan (Xu and Simon, 2005), PLGA (Durucan and Brown, 2000) 
and PLA (Mickiewicz et al., 2002) as composites to overcome their limitations had 
been discussed in previous section. CaP composites described here have distinctive 
features (Ito and Ohgushi, 2005).  
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Ever since the discovery of CNTs by Iijima (1991), a growing attention in 
the applications of CNTs has been focused on their use as reinforcement in 
dissimilar matrix materials due to their outstanding mechanical performance (Treacy 
et al., 1996; Low et al., 2010; Chew et al., 2011; Low et al., 2011). CNTs are being 
investigated for biomedical applications, such as neural implants and tissue scaffolds, 
which utilise their high tensile strength, chemical stability and electrical 
conductivity (Mattson et al., 2000; Correa-Duarte et al., 2004; Gheith et al., 2005; 
Boccaccini and Gerhardt, 2010). Thus, CNTs could be an attractive reinforcement 
for CaP biomaterials.  
 
There is also an interest in developing CaP composites reinforced by multi-
walled CNTs (MWCNTs) and bovine serum albumin (BSA) (Chew et al., 2011; 
Low et al., 2011) in order to improve the mechanical properties of CaPs for 
applications as injectable bone substitutes. At appropriate amounts of BSA, such as 
low concentration, BSAs are able of promoting CaPs crystal growth. This is due to 
BSA could stabilise nuclei and encourage growth of CaP crystals at low 
concentrations of BSA (Low et al., 2011). However, crystal growth seems to be 
slowed down by high BSA coverage at higher concentration (Combes et al., 1999). 
The results of the characterisations of the compressive strength for the pure CPC, 
CPC incorporated with three dissimilar types of MWCNTs (e.g., Pristine MWCNTs, 
hydroxylated MWCNTs (MWCNTs–OH) and carboxylated MWCNTs (MWCNTs–
COOH)) and BSA are shown in Figure 2.1. From the results of the characterisations 
of the compressive strength, the CPC/MWCNTs–OH/BSA composite showed 
significantly enhanced compressive strength (≈16 MPa) if compared to pure CPC 
(≈1 MPa) (Chew et al., 2011). 
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Figure 2.1: The comparison of the compressive strength values of the pure CPC, 
CPC/ MWCNTs, CPC/BSA, CPC/MWCNTs/BSA, CPC/MWCNTs–OH/BSA, and 
CPC/MWCNTs–COOH/BSA composites. *Note that the compressive strength of 
the CPC/BSA composite could not be measured due to the composite was too weak 
to form the required shape for compressive characterisation purposes (Chew et al., 
2011). 
 
Because of the uncertainties about the biocompatibility and toxicity of CNTs 
for clinical applications (Boccaccini and Gerhardt, 2010), further study should focus 
on the in vitro cell biological investigations and on the in vivo performance of the 
CaP composites that contain CNTs (Chew et al., 2011). 
 
Besides, polymers are materials that can be used for multipurpose. They are 
being enthusiastically investigated as materials for medical applications (Mickiewicz, 
2001). In addition, the combination of CaPs with polymers can enhance the 
mechanical properties of the composite (Durucan and Brown, 2000; Mickiewicz et 
al., 2002; Xu and Simon, 2005; Rezwan et al., 2006). For example, Durucan and 
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Brown (2000) made HA–PLGA composite with a tensile strength of 13.3 ± 0.9 MPa, 
a flexural strength of 24.8 ± 1.7 MPa, and Young’s modulus of 2.8 ± 0.3 GPa, which 
showed a modest enhancement over the pure material. Moreover, the polymer 
addition might have other functions, such as biodegradable polymer can act as 
carrier for biomolecules, growth factors and antibiotics, hence, rising the capability 
of tissue engineering construct (Yunos et al., 2008).  However, they show bulk 
degradation, leading to a loss in mechanical properties and they reduce the effect of 
stress-shielding. Thus, they are too weak to be used in most of the load bearing 
situations, and are only recommended in certain clinical indications, such as elbow 
and ankle fractures (Hofmann, 1995; Athanasiou et al., 1996). Since 1960s, some of 
the most popular synthetic polymers (e.g., PLA, PLGA) have been extensively 
studied and approved by Food and Drug Administration (FDA) in clinical 
application as degradable sutures (Li et al., 1990; Behravesh et al., 1999), however, 
not all polymers used are biodegradable biomaterials.  It would be vital to examine 
the biocompatibility, toxicity and behaviour of the CaP composites both in vitro and 
in vivo (Mickiewicz, 2001). 
 
In short, a combination of two materials draws on the advantages of each to 
make an advanced composite biomaterial (Mickiewicz et al., 2002). However, the 
drawbacks of the existing reinforced materials cannot be neglected.  
 
2.4 Nanoshells 
Since nanomaterials are at the leading edge of the speedily developing field 
of nanotechnology, the unique size-dependent properties of nanomaterials make 
them superior and essential in many fields. As a result of their outstanding and 
